Ajanta Pharma launches acid reflux drug in US

Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers in the US market, after receiving final approval from the country's health regulator.

The company has launched the product in the US through its wholly-owned subsidiary, Ajanta Pharma USA Inc, Ajanta Pharma said in a filing to BSE.

The approval from the United States Food and Drug Administration (USFDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg, it added.

The capsules are generic version of Santarus Inc's Zegerid capsules.

The company has 26 abbreviated new drug applications (ANDAs) of which it has received final approvals for 11, tentative nods for 1 ANDA, while 14 are under review with the USFDA, it added.

Shares of Ajanta Pharma were trading at Rs 1,620, up 1.37% in the afternoon trade on BSE.